FAMWX Performance — FAM Value Fund, Institutional Class
Data updated: 2026-08-31
FAMWX returned +7.99% year to date and +8.36% over one year to Jun 2026. Annualised returns are +12.51% over 3 years and +7.51% over 5 years. The fund trailed its US Mid-Cap Value category average: $100 invested three years ago grew to $142, against $148 for the category, and to $108 over one year, against $120. Volatility over the past three years was 13.85% a year. In the 12 months to Jun 2026 the fund lost a net $41.6M, and assets reached $1.82B.
FAMWX Growth of $100
What $100 invested in FAM Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | FAMWX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $108 | $120 |
| 3 years (Jul 2023 – Jun 2026) | $142 | $148 |
| 5 years (Jul 2021 – Jun 2026) | $144 | $154 |
| Since data start (Jul 2019 – Jun 2026) | $232 | $212 |
FAMWX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.99% |
| 1 year | +8.36% |
| 3 years (annualised) | +12.51% |
| 5 years (annualised) | +7.51% |
FAMWX Annual Returns
Calendar-year total returns of FAM Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +7.99% |
| 2025 | +5.11% |
| 2024 | +15.79% |
| 2023 | +16.32% |
| 2022 | −13.96% |
| 2021 | +25.86% |
| 2020 | +39.92% |
| 2019 (Jul–Dec) | +0.08% |
FAMWX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.2% | +4.0% | −7.1% | +6.9% | −1.8% | +4.2% | — | — | — | — | — | — |
| 2025 | +4.6% | −1.4% | −4.0% | −0.1% | +4.7% | +1.2% | −1.2% | +2.3% | +0.4% | −3.1% | +2.7% | −0.6% |
| 2024 | +1.2% | +5.8% | +3.6% | −6.0% | +2.3% | −0.8% | +5.4% | +2.5% | +1.1% | −1.3% | +8.1% | −6.1% |
| 2023 | +6.0% | −2.7% | −0.3% | −0.1% | −3.9% | +8.9% | +2.9% | −0.3% | −5.1% | −2.7% | +8.0% | +6.0% |
| 2022 | −6.4% | −5.3% | +2.7% | −5.7% | +1.0% | −8.4% | +10.0% | −3.7% | −6.8% | +7.4% | +7.5% | −4.9% |
| 2021 | −2.9% | +7.0% | +5.0% | +5.6% | +0.1% | 0.0% | +1.9% | +1.1% | −4.9% | +6.8% | −1.4% | +5.9% |
| 2020 | 0.0% | −0.1% | −0.2% | +10.6% | +5.1% | −0.3% | +5.3% | +4.4% | −2.0% | −1.7% | +10.9% | +3.2% |
| 2019 | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
FAMWX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.85%
- 3-year Sharpe ratio: 0.58 (vs 4.5% risk-free rate)
- Best month: +8.06% (Nov 2024)
- Worst month: −7.08% (Mar 2026)
FAMWX Fund Flows
Monthly money in and out of FAM Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$41.6M
- 12-month gross sales (incl. reinvestments): $146.6M
- Sales ÷ redemptions: 0.78×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $6.8M | $24.9M | −$18.1M |
| May 2026 | $10.0M | $21.2M | −$11.2M |
| Apr 2026 | $10.6M | $17.4M | −$6.9M |
| Mar 2026 | $4.3M | $11.9M | −$7.6M |
| Feb 2026 | $3.9M | $13.2M | −$9.3M |
| Jan 2026 | $7.2M | $15.3M | −$8.1M |
| Dec 2025 | $83.7M | $25.7M | $58.0M |
| Nov 2025 | $2.4M | $11.7M | −$9.2M |
| Oct 2025 | $6.4M | $14.9M | −$8.6M |
| Sep 2025 | $2.9M | $11.7M | −$8.9M |
| Aug 2025 | $2.5M | $9.1M | −$6.6M |
| Jul 2025 | $6.1M | $11.1M | −$5.0M |
FAMWX Assets Under Management
Net assets of FAM Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.82B |
| 2026-03-31 | $1.70B |
| 2025-12-31 | $1.74B |
| 2025-09-30 | $1.81B |
| 2025-06-30 | $1.80B |
| 2025-03-31 | $1.73B |
| 2024-12-31 | $1.76B |
| 2024-09-30 | $1.80B |
| 2024-06-30 | $1.66B |
| 2024-03-31 | $1.76B |
| 2023-12-31 | $1.60B |
| 2023-09-30 | $1.46B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.